Uptravi 1600MCG
Ended Awarded Last action
- Contract number
- 36C26124N0138
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $164,497
Award facts
- Contract value 100% obligated
- $164,497.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Las Vegas, NV 89086, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $76,990 | |
| Original award | $87,507 |
About this award
Actelion Pharmaceuticals US, Inc. was awarded a $164,497.03 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration and Department of Veterans Affairs. The order is for the pulmonary arterial hypertension medication UPTRAVI 1600MCG to be delivered to facilities in North Las Vegas, Nevada by September 30, 2024. No set-aside designation was used for this award. Funding comes from the Veterans Health Administration within the Department of Veterans Affairs, which operates integrated networks of medical centers and clinics serving veterans nationwide through its Veterans Integrated Service Network 21. Actelion Pharmaceuticals holds the Pharmaceuticals and Drugs FSS contract allowing federal customers to procure needed prescription medications through pre-negotiated pricing, as well as a $60 million blanket purchase agreement against the same schedule to facilitate agency access to therapies for pulmonary arterial hypertension through May 2024.
Quick answers
Who was awarded contract 36C26124N0138?
36C26124N0138 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C26124N0138 worth?
The government has obligated $164,497 on 36C26124N0138.
Is contract 36C26124N0138 an order under another contract?
Yes. 36C26124N0138 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0138 competed?
The extent of competition for 36C26124N0138 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award